
Pajson Agro H1 FY27: PAT down 12% YoY on margin compression despite 21% revenue growth
Pajson Agro's standalone H1 FY27 revenue from operations rose 21.1% YoY to ₹143.39 Cr (from ₹118.37 Cr in H1 FY26), but PAT fell 11.6% YoY to ₹12.56 Cr (from ₹14.21 Cr) as EBITDA margin compressed to roughly 14.2% from roughly 17.8% a year earlier. Sequentially the picture is better — PAT rose 18.8% QoQ from H2 FY26's ₹10.57 Cr and EBITDA margin improved from roughly 12.2% — but per the YoY-primary read, profitability lagged revenue growth this half. The squeeze sits on two lines: the raw-material cost ratio (cost of materials consumed/revenue) rose to 83.1% from 81.2% YoY, and finance costs more than doubled to ₹2.26 Cr from ₹1.07 Cr as short-term borrowings nearly doubled to ₹59.25 Cr (from ₹34.06 Cr at FY26-end) to fund a large inventory build (₹95.69 Cr from ₹37.59 Cr) and ongoing capex. Capital work-in-progress jumped to ₹16.37 Cr from ₹0.33 Cr, consistent with construction of the Greenfield facility; none of that capacity is yet contributing to revenue. Management's FY26 Q4 concall had guided to roughly 20% FY27 revenue growth from existing operations — H1's +21.1% YoY is in line to slightly ahead — and to EBITDA margin recovering to a 15-16% steady state aided by forex hedging and operational efficiencies. The 14.2% margin posted is still short of that band, though it is recovering sequentially from H2 FY26's 12.2%, so the print tracks the guided direction without yet reaching the target. No management press release accompanied this filing to cross-check that framing. As a BSE SME-platform microcap (₹23.81 Cr paid-up capital, listed December 2025 at a ₹108/share premium) it carries no visible analyst coverage, so vsStreet is unknown rather than estimated. Concurrently, the company disclosed a board meeting on November 4 to consider securities issuance and an ESOP, and had utilised ₹35.64 Cr of its ₹74.45 Cr IPO proceeds by period-end, including ₹18.27 Cr of the ₹57 Cr earmarked for the new manufacturing unit.
Key Highlights
- Revenue from operations up 21.1% YoY to ₹143.39 Cr (H1 FY27 vs ₹118.37 Cr H1 FY26); +4.4% QoQ vs H2 FY26's ₹137.35 Cr.
- Net profit fell 11.6% YoY to ₹12.56 Cr (from ₹14.21 Cr), even as it rose 18.8% QoQ from ₹10.57 Cr — the YoY-primary read shows margin pressure, not a loss.
- EBITDA margin compressed to ~14.2% from ~17.8% YoY (~360 bps), though it recovered sequentially from ~12.2% in H2 FY26 — still below management's 15-16% guided steady state.
- Finance costs more than doubled YoY to ₹2.26 Cr (from ₹1.07 Cr) on short-term borrowings nearly doubling to ₹59.25 Cr (from ₹34.06 Cr at FY26-end).
- Raw material cost ratio (cost of materials/revenue) rose to 83.1% from 81.2% YoY, the other main squeeze on margin.
- Capital work-in-progress jumped to ₹16.37 Cr from ₹0.33 Cr, consistent with the Greenfield facility management guided toward Q4 commercial production.
- EPS (not annualised) ₹5.27 for H1 FY27 vs ₹8.12 in H1 FY26.
Price Impact
More from PAJSON